Novel protein–inhibitor interactions in site 3 of Ca(2+)-bound S100B as discovered by X-ray crystallography

Structure-based drug discovery is under way to identify and develop small-molecule S100B inhibitors (SBiXs). Such inhibitors have therapeutic potential for treating malignant melanoma, since high levels of S100B downregulate wild-type p53 tumor suppressor function in this cancer. Computational and X...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Acta Crystallogr D Struct Biol
Hlavní autoři: Cavalier, Michael C., Melville, Zephan, Aligholizadeh, Ehson, Raman, E. Prabhu, Yu, Wenbo, Fang, Lei, Alasady, Milad, Pierce, Adam D., Wilder, Paul T., MacKerell, Alexander D., Weber, David J.
Médium: Artigo
Jazyk:Inglês
Vydáno: International Union of Crystallography 2016
Témata:
Research Papers
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4908867/
https://ncbi.nlm.nih.gov/pubmed/27303795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1107/S2059798316005532
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky